Ofloxacin 50 mg/5 ml Oral Suspension (60 ml)

Ofloxacin 50 mg/5 ml Oral Suspension is a reliable broad-spectrum antibiotic designed to treat a wide range of bacterial infections. Indicated for respiratory tract, urinary tract (UTI), gastrointestinal, and skin and soft tissue infections, it effectively inhibits bacterial DNA replication to promote fast recovery. Formulated in a pleasant orange flavor in a shatter-resistant 60 ml PET bottle.

Ofloxacin 50 mg/5 ml Oral Suspension (60 ml) is an antibacterial pharmaceutical formulation containing Ofloxacin, a fluoroquinolone antibiotic used to treat certain bacterial infections caused by susceptible microorganisms. Ofloxacin works by inhibiting bacterial enzymes known as DNA gyrase and topoisomerase IV, which are essential for bacterial DNA replication, repair, and multiplication. By interfering with these processes, it helps stop the growth of susceptible bacteria and supports the treatment of specific bacterial infections when antibiotic therapy is clinically indicated. Depending on the diagnosis, local treatment guidelines, and bacterial susceptibility, Ofloxacin may be prescribed for selected gastrointestinal, urinary tract, or other bacterial infections. It is not effective against viral illnesses such as the common cold or influenza, and it should not be used for every episode of diarrhoea or fever. The 50 mg/5 ml concentration and 60 ml bottle pack provide a liquid oral dosage form that may be easier to administer to patients who have difficulty swallowing tablets. The appropriate dose and duration depend on the patient's age, body weight, kidney function, type of infection, and the product's approved prescribing information. Possible side effects include nausea, vomiting, abdominal discomfort, diarrhoea, headache, and dizziness. Ofloxacin can also cause uncommon but potentially serious adverse effects involving tendons, nerves, the central nervous system, and heart rhythm; fluoroquinolone antibiotics are therefore reserved for appropriate indications after considering their risks and alternatives. Use in children requires particular medical supervision because of potential effects on developing joints and other safety considerations. Patients should inform their healthcare professional about kidney problems, heart rhythm disorders, seizure history, and other medicines they take. Ofloxacin 50 mg/5 ml Oral Suspension (60 ml) should be used only when prescribed by a qualified healthcare professional, with the exact dose measured using an appropriate oral measuring device and the suspension prepared or shaken according to the product label.